Berenberg Bank Keeps Their Buy Rating on AstraZeneca (AZN)
I'm PortAI, I can summarize articles.
Berenberg Bank has reaffirmed its Buy rating on AstraZeneca (AZN) with a price target of £145.00, while the shares closed at £13,466.00. Analyst Luisa Hector, noted for her 4-star rating and 64.52% success rate, highlights a Moderate Buy consensus for AstraZeneca, with an average price target of £14,197.23, indicating a potential upside of 5.43%. Bernstein also maintains a Buy rating with a £180.00 target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments